Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Primary Biliary Cirrhosis
100%
Chronic Hepatitis B
62%
Ursodeoxycholic Acid
52%
Hazard Ratio
43%
Liver Transplantation
41%
Hepatocellular Carcinoma
33%
Liver Cirrhosis
28%
Obeticholic Acid
27%
Systematic Review
27%
Hepatitis B Antigen
21%
Cohort Analysis
21%
Alkaline Phosphatase
20%
Event Free Survival
19%
Recurrent Disease
16%
Cholangiocarcinoma
16%
Meta-Analysis
16%
Odds Ratio
16%
Fibrosis
16%
Placebo
16%
Decompensated Liver Cirrhosis
15%
Hepatitis B Virus
15%
Diseases
14%
Randomized Controlled Trial
14%
Prevalence
14%
Alanine Aminotransferase
12%
Clinical Trial
12%
Hepatitis B(e) Antigen
12%
Colorectal Carcinoma
11%
Comorbidity
11%
Retrospective Cohort Study
11%
Liver Disease
11%
Metabolic Dysfunction-Associated Steatotic Liver Disease
11%
Congenital Diaphragm Hernia
11%
Alagille Syndrome
11%
Autoimmune Hepatitis
11%
Endoscopic Retrograde Cholangiopancreatography
11%
COVID-19
11%
Overall Survival
10%
Bilirubin
10%
Hepatitis C Virus
10%
Graft Failure
10%
Polyacrylamide Gel Electrophoresis
8%
Long-Term Outcome
8%
Proportional Hazards Model
8%
Median Follow Up
7%
Cumulative Incidence
7%
Retreatment
7%
Graft Survival
7%
Bile Acid
7%
Hepatitis B
7%
Immunology and Microbiology
Hepatitis B
67%
Hepatitis B Antigen
45%
HBsAg
45%
Primary Biliary Cirrhosis
39%
Hepatitis B(e) Antigen
33%
Pegylated Interferon
27%
Hepatitis B Virus
25%
Liver Transplantation
24%
Cirrhosis
22%
Prevalence
18%
Hepatitis C Virus
17%
Microbiome
16%
Hepatitis C
15%
Tenofovir
13%
Primary Sclerosing Cholangitis
11%
Hepatitis B Core Antibody
11%
Interferon Type I
11%
Autoimmune Hepatitis
11%
Normal Human
11%
Event Free Survival
11%
Comorbidity
11%
Infection
9%
Inflammatory Bowel Disease
9%
Human Immunodeficiency Virus
8%
Agonist
8%
Infectious Disease
8%
Interferon Alfa
7%
Phosphatase
7%
Overall Survival
6%
Arm
6%
Poly(ethylene Glycol)
6%
Polyethylene Glycol
6%
Alanine
6%
HBV DNA
5%
Viral Load
5%
COVID-19
5%
Booster Dose
5%
Immunogenicity
5%
HBcAg
5%
Hepatitis A
5%
Virus Vaccine
5%
Toll-Like Receptor
5%
Viral Disease
5%
DNA Methylation
5%
Methylation
5%
Rituximab
5%
Virus Reactivation
5%
Cohort Effect
5%
Linguistics
5%
Metabolic Dysfunction-Associated Steatotic Liver Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Primary Biliary Cirrhosis
50%
Chronic Hepatitis B
27%
Ursodeoxycholic Acid
22%
Hepatitis C Virus
20%
Obeticholic Acid
18%
Hepatitis B(e) Antigen
18%
Liver Cirrhosis
17%
Hepatitis B Antigen
13%
Cohort Study
13%
Placebo
13%
Liver Disease
12%
Prevalence
12%
Alanine Aminotransferase
11%
Diseases
11%
Chronic Hepatitis C
11%
Event Free Survival
11%
Peginterferon
11%
Autoimmune Hepatitis
11%
Recurrent Disease
11%
Hepatitis C
9%
Fibrosis
9%
Remission
8%
Alkaline Phosphatase
8%
Clinical Trial
7%
Antiviral Therapy
7%
Alpha Interferon
7%
Liver Cell Carcinoma
7%
Infection
6%
Antiviral Drug
6%
Interferon
6%
End Stage Liver Disease
6%
Antivirus Agent
6%
Maralixibat
5%
Alagille Syndrome
5%
Comorbidity
5%
Virus Vaccine
5%
Coronavirinae
5%
Hepatitis A
5%
Vaccine Development
5%
Adult Respiratory Distress Syndrome
5%
Suppository
5%
Ischemia
5%
Tacrolimus
5%
Proctitis
5%
Syndrome
5%
Opiate Agonist
5%
Toll Like Receptor 7
5%
Drug Screening
5%
Beclometasone
5%
Pharmacokinetics
5%
